RedHill Biopharma Ltd. reports

Company location
Tel Aviv, Israel
RedHill Biopharma Ltd. has filed 1,011 SEC EDGAR filings since 01 Oct 2012

SEC filing history

Showing 151-175 of 1,000 matching filings.

Per page
25
Current page
7
UPLOAD File 333-276979

UPLOAD filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
13 Feb 2024
Reporting date
13 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-504349

D filing

Filing date
05 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87280

SCHEDULE 13G

Filing date
02 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87280

SC 13G

Filing date
01 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
26 Jan 2024
Reporting date
26 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
26 Jan 2024
Reporting date
26 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-258259

424B5

Filing date
26 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
25 Jan 2024
Reporting date
25 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
25 Jan 2024
Reporting date
25 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87280

REDHILL BIOPHARMA LTD.

Filing date
08 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87280

RDHL 13GA 1.02.24

Filing date
02 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
20 Dec 2023
Reporting date
20 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
12 Dec 2023
Reporting date
12 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
06 Dec 2023
Reporting date
06 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
04 Dec 2023
Reporting date
04 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
01 Dec 2023
Reporting date
01 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
27 Nov 2023
Reporting date
27 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
16 Nov 2023
Reporting date
16 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
14 Nov 2023
Reporting date
14 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-274957

EFFECT filing

Filing date
26 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-274957

424B3

Filing date
26 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-3/A File 333-274957

F-3/A

Filing date
23 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .